YI trade ideas
The explosive growth of E-Pharmacy in China We have already witnessed how e-commerce has taken the likes of Alibaba, JD.com, Pinduoduo, Baozun, etc registering strong growth over the past few years in China.
This company, 1 Yaowang is serving a niche market unlike the big boys - Alibaba and JD.com in this e-pharmacy space in China.
Read some articles here and here . I like its Q2 results and due to its small market cap, it is still not a favourite of the institutional players yet.
You can see from chart that there is accumulation between price 5.60-8 dollars range for the last 8 months or so.
I will be initiating a long position tonight.
YI - Bullish Bounce - Can It Recover? RISKY..111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment engages in the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.
SHORT INTEREST
32.07K 08/15/19
P/E Current
-1.99
P/E Ratio (with extraordinary items)
-2.73
Average Recommendation: BUY
Average Target Price: 98.42 (Most likely wrong)